These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1120 related articles for article (PubMed ID: 302878)

  • 1. ["Transfer factor" in ophthalmology (author's transl)].
    Rocha H
    Klin Monbl Augenheilkd; 1977 Jul; 171(1):63-70. PubMed ID: 302878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The erythrocyte-rosette forming cell (E-RFC) count and results of treatment with transfer factor in herpes simplex keratitis (author's transl)].
    Xie LX
    Zhonghua Yan Ke Za Zhi; 1981 Jul; 17(4):204-7. PubMed ID: 6802605
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of transfer factor on the immunity state of patients with bronchopulmonary cancer. A report on 12 cases (author's transl)].
    Hainaut J; Challan-Belval P; Haguenauer G; Pellegrin J; Allard P; Kermarec J
    Ann Med Interne (Paris); 1979; 130(11):517-21. PubMed ID: 317697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathobiology of sarcoidosis.
    James DG; Neville E
    Pathobiol Annu; 1977; 7():31-61. PubMed ID: 339151
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of isolated cellular immune defect with transfer factor (author's transl)].
    Göring HD; Fiehring C; Schröder I
    Dermatol Monatsschr; 1980 Feb; 166(2):81-7. PubMed ID: 6967428
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspecific transfer factor in children with Hodgkin's disease.
    Pasino M; Vadalà CR; Tonini GP; Comelli A; Perutelli P
    Boll Ist Sieroter Milan; 1976; 55(2):168-73. PubMed ID: 1088071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Augmentation of lymphocyte transformation by human dializable transfer factor and its target cell (author's transl)].
    Okada M
    Arerugi; 1982 Feb; 31(2):69-80. PubMed ID: 6981395
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy with transfer factor in a case of recidivating herpes with polymorphous erythema].
    García-Calderón PA; Alomar A; García-Calderón JV; Vich JM; De Moragas JM
    Med Cutan Ibero Lat Am; 1977; 5(5):361-6. PubMed ID: 368459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defence systems of the body, immunosuppression and immunotherapy.
    James DG
    J R Nav Med Serv; 1976; 62(2):60-72. PubMed ID: 787517
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immune profile in melanoma patients. I. PHA--stimulation of circulating lymphocytes and number of T- and B-lymphocytes (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(6):559-64. PubMed ID: 310289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell immunity responses in patients with widespread neoplasias following administration of transfer factor (author's transl)].
    Simó-Camps E; Vich JM; García Calderón PA; Bofill D; Grau A; Anguiz A; Forcadell I
    Med Clin (Barc); 1980 May; 74(10):403-7. PubMed ID: 6968012
    [No Abstract]   [Full Text] [Related]  

  • 12. E-rosette forming count determination and transfer factor treatment in herpetic simplex keratitis.
    Xie LX; Kang FY; Du YX
    Chin Med J (Engl); 1983 Nov; 96(11):860-4. PubMed ID: 6428821
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease.
    Jain S; Thomas HC; Sherlock S
    Clin Exp Immunol; 1977 Oct; 30(1):10-5. PubMed ID: 606432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
    Khan A; Thometz D; Garrison O; Hill JM
    Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular and genetic aspects of antibody formation (author's transl)].
    Sado T
    Tanpakushitsu Kakusan Koso; 1975 Jul; 20(9):833-43. PubMed ID: 1103236
    [No Abstract]   [Full Text] [Related]  

  • 16. [Increased immune reactivity in systemic lupus erythematosus. III. Different in vitro stimulation of lymphocytic populations by mitogenic serum factors (author's transl)].
    Günther W; Diezel W; Meffert H; Sönnichsen N
    Dermatol Monatsschr; 1978 Oct; 164(10):711-4. PubMed ID: 310779
    [No Abstract]   [Full Text] [Related]  

  • 17. [Concepts of stimulating immunotherapy].
    Aiuti F; Montella F
    Minerva Med; 1982 Apr; 73(15):895-8. PubMed ID: 6176915
    [No Abstract]   [Full Text] [Related]  

  • 18. [The lymphocytes and their receptors (author's transl)].
    Ramos-Niembro F; Díaz-Jouanen E
    Rev Invest Clin; 1978; 30(2):161-71. PubMed ID: 307796
    [No Abstract]   [Full Text] [Related]  

  • 19. [Human transfer factor. II. Clinical results with the large pool transfer factor].
    Metzner G; Fricke HJ; Schröder D; Göring HD; Franke W; Karl M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):526-39. PubMed ID: 6196269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of corneal herpes with lymphocyte extract dialysates (preliminary study)].
    Vignat JP; Hainaut J; Bourgeois H
    Bull Soc Ophtalmol Fr; 1978; 78(8-9):551-4. PubMed ID: 751750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.